Evidence map›Paper›PMID 29930510›Full record

ArticleFrontiers in pharmacology2018

α

Saïd M'Dahoma, Matthieu Poitevin, Eric Dabala, Hugo Payan, Cecilia Gabriel, Elisabeth Mocaër, Sylvie Bourgoin, Michel Hamon

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Role of Melatonin in the Regulation of Pain.Journal of pain research · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Saïd M'DahomaINSERM U894, Centre de Psychiatrie et Neurosciences, Paris, France.
Matthieu PoitevinINSERM U894, Centre de Psychiatrie et Neurosciences, Paris, France.
Eric DabalaINSERM U894, Centre de Psychiatrie et Neurosciences, Paris, France.
Hugo PayanINSERM U894, Centre de Psychiatrie et Neurosciences, Paris, France.
Cecilia GabrielInstitut de Recherches Internationales Servier, Suresnes, France.
Elisabeth MocaërInstitut de Recherches Internationales Servier, Suresnes, France.
Sylvie BourgoinINSERM U894, Centre de Psychiatrie et Neurosciences, Paris, France.
Michel HamonINSERM U894, Centre de Psychiatrie et Neurosciences, Paris, France.
Institut de Psychiatrie et Neurosciences de Paris · FRInserm · FRServier (France) · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Previous data showed that neuropathic pain induced by mechanical lesion of peripheral nerves has specific characteristics and responds differently to alleviating drugs at cephalic versus extracephalic level. This is especially true for tricyclic antidepressants currently used for alleviating neuropathic pain in humans which are less effective against cephalic neuropathic pain. Whether this also applies to the antidepressant agomelatine, with its unique pharmacological properties as MT

Indexed as

agomelatinechronic constriction injurygabapentininfraorbital nervemechanical allodynianeuropathic ratssciatic nerveα2- and β2-adrenoreceptors

Identifiers

PMID29930510
PMCPMC5999781
OpenAlexW2805137229

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.